Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000810030 | SCV000950216 | uncertain significance | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2022-08-31 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 10 of the SEC23B gene. It does not directly change the encoded amino acid sequence of the SEC23B protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201883785, gnomAD 0.1%). This variant has been observed in individual(s) with dyserythropoietic anemia type 2 (PMID: 34201899). ClinVar contains an entry for this variant (Variation ID: 654136). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001509051 | SCV001715553 | uncertain significance | not provided | 2020-11-03 | criteria provided, single submitter | clinical testing |